Dacomitinib

CHEMBL2105719 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
469.9 g/mol
LogP
4.4
Phase
4

A targeted cancer therapy that inhibits the epidermal growth factor receptor (EGFR) and related proteins involved in tumor cell growth. It is used to treat certain types of lung cancer with specific genetic mutations.

الوزن الجزيئي

469,9000 g/mol

LogP

4,40

TPSA

79,40 Ų

قاعدة ليبينسكي للخمسة

ناجح

المجالات العلاجية

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1.O

InChI

InChI=1S/C24H25ClFN5O2.H2O/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31;/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29);1H2/b6-5+;

Molecular Formula

C24H25ClFN5O2

HBD / HBA

2 / 7

الروابط القابلة للدوران

7

الذرات الثقيلة

33

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

A targeted cancer therapy that inhibits the epidermal growth factor receptor (EGFR) and related proteins involved in tumor cell growth. It is used to treat certain types of lung cancer with specific genetic mutations.

Yes, Dacomitinib is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2105719. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 11511120. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.